Stocks · Health care · Pharmaceutical Preparations

BIOMARIN PHARMACEUTICAL INC

BMRN Clue Score68

United States Fiscal year ends December CIK 0001048477 Results filed 2 Nov 2026

Add to watchlist

What the insiders did Net selling

By person

32 insiders · 413 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Jean Jacques Bienaime

Director

—

$133.62M (166) scheduled

−$133.62M

473,892

0.2448%

$31.41M

+371.8%

Henry J Fuchs

President, Worldwide R&D

—

$41.37M (27) scheduled

−$41.37M

185,074

0.0956%

$12.27M

+65.5%

George Eric Davis

EVP, Chief Legal Officer

—

$29.02M (36) scheduled

−$29.02M

61,003

0.0315%

$4.04M

−14.8%

Jeffrey Robert Ajer

EVP, Chief Commercial Officer

—

$16.57M (47) scheduled

−$16.57M

66,767

0.0345%

$4.43M

+63.4%

Daniel K Spiegelman

EVP, Chief Financial Officer

—

$9.06M (11)

−$9.06M

47,686

0.0246%

$3.16M

−38.4%

V Bryan Lawlis

Director

—

$8.33M (21) scheduled

−$8.33M

33,140

0.0171%

$2.20M

+158.7%

Brian Mueller

EVP, Chief Financial Officer

—

$7.36M (24) scheduled

−$7.36M

123,314

0.0637%

$8.17M

+736.4%

Charles Greg Guyer

EVP, Chief Technical Officer

—

$2.95M (5)

−$2.95M

84,140

0.0435%

$5.58M

+9,560%

Robert Baffi

President, Global Mfg/Tech Ops

—

$2.93M (5)

−$2.93M

189,020

0.0976%

$12.53M

+27.2%

Richard A Meier

Director

—

$1.21M (6) scheduled

−$1.21M

127,426

0.0658%

$8.45M

+359.0%

Alan Lewis

Director

—

$1.16M (3) scheduled

−$1.16M

25,590

0.0132%

$1.70M

+34.6%

David E I Pyott

Director

$1.00M (2)

—

+$1.00M

49,750

0.0257%

$3.30M

+1,640%

Michael G Grey

Director

—

$682.28K (2) scheduled

−$682.28K

42,840

0.0221%

$2.84M

+54.3%

Erin Burkhart

GVP, Chief Accounting Officer

—

$560.45K (5) scheduled

−$560.45K

14,173

0.0073%

$939.44K

—

Gregory R Friberg

EVP, Chief R&D Officer

—

$558.62K (2)

−$558.62K

47,732

0.0247%

$3.16M

+11,893%

Willard H Dere

Director

—

$547.59K (1)

−$547.59K

46,440

0.0240%

$3.08M

+1,659%

Dennis Slamon

Director

—

$501.01K (6)

−$501.01K

31,299

0.0162%

$2.07M

+299.5%

Mark J Alles

Director

$314.47K (1)

—

+$314.47K

15,095

0.0078%

$1.00M

—

Elaine J Heron

Director

—

$168.05K (2)

−$168.05K

97,720

0.0505%

$6.48M

+163.1%

Cristin Hubbard

EVP, Chief Commercial Officer

—

$17.72K (1) scheduled

−$17.72K

42,472

0.0219%

$2.82M

+52,990%

Alexander Hardy

Chief Executive Officer

—

—

—

214,635

0.1109%

$14.23M

—

Robert J. Hombach

Director

—

—

—

49,360

0.0255%

$3.27M

—

Elizabeth M Anderson

Director

—

—

—

41,940

0.0217%

$2.78M

—

Maykin Ho

Director

—

—

—

35,500

0.0183%

$2.35M

—

Rashmi Virendra Ramchandani

VP, Chief Accounting Officer

—

—

—

25,610

0.0132%

$1.70M

—

Barbara W. Bodem

Director

—

—

—

21,045

0.0109%

$1.39M

+420,800%

Mark J Enyedy

Director

—

—

—

21,040

0.0109%

$1.39M

—

Athena Countouriotis

Director

—

—

—

21,040

0.0109%

$1.39M

—

Andrea Acosta

GVP, Chief Accounting Officer

—

—

—

18,122

0.0094%

$1.20M

+20.3%

Timothy P Walbert

Director

—

—

—

17,270

0.0089%

$1.14M

—

Ian T Clark

Director

—

—

—

14,490

0.0075%

$960.46K

—

Robert M Plenge

Director

—

—

—

6,140

0.0032%

$406.98K

—